Showing results (131-140 of 420) with videos related to
Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapyJ A Sparano, P H Wiernik, A Leaf, et al.Medical Oncology (Northwood, London, England)|November 20, 1998
Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literatureM Colović, G Janković, J Bila, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patientP Etkind, J Du, A Khan, et al.American Journal of Hematology|July 1, 1985
Transformation of myeloma into Ph1-negative CML with plasma cell antigensE Paietta, M Goldstein, P Papenhausen, et al.Cancer Research|December 1, 1979
Pharmacokinetic studies during phase I trials of high-dose thymidine infusionsD S Zaharko, B J Bolten, D Chiuten, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
A phase I trial of continuous infusion VP16-213 (etoposide)J Aisner, D A Van Echo, M Whitacre, et al.Experimental Hematology|August 1, 1986
Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantationN Ciobanu, E Paietta, M Andreeff, et al.Cancer|February 15, 1991
Complete remission in refractory anaplastic adult Wilms' tumor treated with cisplatin and etoposideJ A Sparano, J B Beckwith, S Mitsudo, et al.Cancer|December 15, 1996
Extramedullary acute promyelocytic leukemiaP H Wiernik, R De Bellis, P Muxi, et al.Leukemia|December 1, 1987
The 5q-- deletion: correlation of breakpoints with the immunophenotype of leukemic blast cellsE Paietta, P Papenhausen, R Gucalp, et al.Pageof 42